
Pediatrician

No OPD information available
Prader-Willi Syndrome
Ohn Nyunt is a male medical professional who specializes in helping patients with Prader-Willi Syndrome, a rare genetic disorder. He is known for his expertise in treating this condition and providing special care to those affected by it.
Ohn Nyunt works closely with patients, using his skills and knowledge to improve their health and well-being. He communicates effectively with patients, showing empathy and understanding, which helps build trust between them. Patients feel comfortable sharing their concerns with Ohn Nyunt, knowing that he will provide the best possible care for them.
To stay updated with the latest medical knowledge and research, Ohn Nyunt regularly attends conferences, reads medical journals, and participates in continuing education programs. This dedication to learning ensures that he can offer the most advanced treatments and care to his patients.
In his interactions with colleagues, Ohn Nyunt is known for his collaborative approach. He values teamwork and actively engages with other medical professionals to provide comprehensive care to patients. His positive attitude and willingness to work with others make him a respected member of the medical community.
Ohn Nyunt's work has had a positive impact on many patients' lives. Through his expertise and dedication, he has helped improve the health and quality of life of individuals with Prader-Willi Syndrome. His commitment to providing excellent care and support has made a difference in the lives of those he treats.
One of Ohn Nyunt's notable publications is a "Letter to the Editor" in the Journal of Pediatrics and Child Health. Additionally, he has been involved in a Phase 3 clinical trial called "CARE-PWS," which aimed to assess the efficacy, safety, and tolerability of a treatment for Prader-Willi Syndrome.
Overall, Ohn Nyunt is a compassionate and skilled medical professional who is dedicated to helping patients with Prader-Willi Syndrome. His commitment to staying informed, collaborating with colleagues, and making a positive impact on patients' lives sets him apart in the field of healthcare.
Enrollment Status: Completed
Published: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
